Analysis of Down syndrome failed to be diagnosed after prenatal screening A multicenter study

被引:7
|
作者
Jiang, Tao [1 ]
Ding, Jie [2 ]
Zhang, Xiao-Qing [3 ]
Zhang, Xiao-Juan [1 ]
Zhang, Bin [3 ]
Wang, Ting [2 ]
Yu, Bin [3 ]
机构
[1] Nanjing Med Univ, Obstet & Gynecol Hosp, Nanjing, Jiangsu, Peoples R China
[2] Nanjing Med Univ, Suzhou Municipal Hosp, Suzhou 215000, Peoples R China
[3] Nanjing Med Univ, Changzhou Woman & Children Hlth Hosp, Changzhou 213003, Jiangsu, Peoples R China
关键词
biomarkers; Down syndrome; missed diagnosis; prenatal diagnosis; prenatal screening; serum; FREE BETA-HCG; 2ND TRIMESTER; ALPHA-FETOPROTEIN;
D O I
10.1097/MD.0000000000007166
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To analyze the characters of Down syndrome (DS) who failed to be diagnosed after prenatal screening and hope to be able to improve the programs of prenatal screening and reduce the missed diagnosis of DS. In this multicenter study, we collected the missed cases from 3 prenatal diagnosis centers and analyzed their characters. A total of 126 DS babies failed to be diagnosed after prenatal screening. Their mothers accepted the prenatal screening in second trimester. We collected the mothers' blood and detected the levels of alpha-fetoprotein (AFP) and the free beta subunit of human chorionic gonadotropin (f beta hCG) by time-resolved fluoroimmunoassay. The values were also presented as multiples of the median (MoM) and determined the risk of carrying a fetus with DS by Wallace LifeCycle Elipse analysis software. Compared with normal control group, the level of fbhCG and hCG MoM were dramatically increased, while AFP and AFP MoM were decreased. The area under the receiver-operating-characteristic curve of trisomy 21 was 0.8387 for hCG-MoM and AFP-MoM testing. The sensitivity, specificity, positive predictive value, and negative predictive value were 84.6%, 74.8%, 75.4%, and 83.6%, respectively. Meanwhile, the prediction mode was '' 0.39957+1.90897(*) HCG-MOM -3.32713(*) AFP-MOM". It was worthwhile noting that the risk of 65.9% DS missed diagnosis group were higher than 1/1000, 92.9% higher than 1/3000. However, 72.5% cases in normal control group were lower than 1/3000. Only 9.2% mothers would be higher than the value of risk in 1/1000. The prediction mode of hCG MoM and AFP MoM might be able to help us reduce the missed diagnosis. It is also necessary to adjust more reasonable range of noninvasive prenatal testing with further clinical researches.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] Ethnic differences in participation in prenatal screening for Down syndrome: A register-based study
    Fransen, Mirajm P.
    Schoonen, Marleen H. M. H. J. D.
    Mackenbach, Johan P.
    Steegers, Eric A. P.
    de Koning, Harry J.
    Laudy, Jacqueline A. M.
    Galjaard, Robert-Jan
    Looman, Caspar W. N.
    Essink-Bot, Marie-Louise
    Wildschut, Hajo I. J.
    PRENATAL DIAGNOSIS, 2010, 30 (10) : 988 - 994
  • [42] Experience in the Application of Non-invasive Prenatal Screening for the Detection of Down Syndrome in Russia: A Retrospective Cohort Study
    Kudryavtseva, Elena, V
    Kovalev, Vladislav V.
    Baranov, Igor I.
    Dektyarev, Andrew A.
    INTERNATIONAL JOURNAL OF WOMENS HEALTH AND REPRODUCTION SCIENCES, 2022, 10 (04): : 180 - 185
  • [43] Application of proteomics for prenatal diagnosis of Down syndrome: Systematic review and a meta-analysis
    Yu, Bin
    Wang, Jing
    Wang, Qiu-wei
    Huang, Rui-ping
    Shao, Shi-he
    AFRICAN JOURNAL OF BIOTECHNOLOGY, 2011, 10 (80): : 18556 - 18563
  • [44] Application of droplet digital PCR for prenatal screening of Down syndrome
    Wu, Manwu
    Yang, Zhihao
    Yu, Xinzhong
    Qian, Feiyan
    Qian, Lei
    Li, Wei
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2018, 45 (02) : 231 - 236
  • [45] Down Syndrome in India-Diagnosis, Screening, and Prenatal Diagnosis
    Verma, Ishwar C.
    Lall, Meena
    Puri, Ratna Dua
    CLINICS IN LABORATORY MEDICINE, 2012, 32 (02) : 231 - +
  • [46] Prenatal screening, ethics and Down's syndrome: A literature review
    Alderson, P
    NURSING ETHICS, 2001, 8 (04) : 360 - 374
  • [47] Assessment of the value of reporting partial screening results in prenatal screening for Down syndrome
    Hackshaw, AK
    Wald, NJ
    PRENATAL DIAGNOSIS, 2001, 21 (09) : 737 - 740
  • [48] Prenatal screening for Down syndrome in England and Wales and population-based birth outcomes
    Smith-Bindman, R
    Chu, P
    Bacchetti, P
    Waters, JJ
    Mutton, D
    Alberman, E
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2003, 189 (04) : 980 - 985
  • [49] Uptake of Noninvasive Prenatal Testing in Chinese Women following Positive Down Syndrome Screening
    Poon, C. F.
    Tse, W. C.
    Kou, K. O.
    Leung, K. Y.
    FETAL DIAGNOSIS AND THERAPY, 2015, 37 (02) : 141 - 147
  • [50] The Urinary Peptidome as a Noninvasive Biomarker Development Strategy for Prenatal Screening of Down's Syndrome
    Shan, Dan
    Wang, Hao
    Khatri, Prekshya
    Niu, Yue
    Song, Wei
    Zhao, Shenglong
    Jiang, Yan
    Ma, Qingwei
    Liu, Xinchao
    Zhang, Rong
    Wang, Wei
    Yin, Chenghong
    OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY, 2019, 23 (09) : 439 - 447